(Q34005743)

30 July 2017

1 reference

title

HIV-1 gp41 and type I interferon: sequence homology and biological as well as clinical implications (English)

1 reference

30 July 2017

Chen YH

1

1 reference

30 July 2017

Xiao Y

series ordinal

2

1 reference

30 July 2017

Dierich MP

series ordinal

3

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

22

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

61-66

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:22:1:61

30 July 2017

exact match

0 references

cites work

Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection

1 reference

12 December 2020

Definition of receptor binding domains in interferon-alpha

1 reference

12 December 2020

Retrovirally mediated IFN-beta transduction of macrophages induces resistance to HIV, correlated with up-regulation of RANTES production and down-regulation of C-C chemokine receptor-5 expression

1 reference

12 December 2020

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

12 December 2020

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

12 December 2020

Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapy

1 reference

12 December 2020

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

12 December 2020

HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.

1 reference

12 December 2020

The regulation of expression of major histocompatibility complex products

1 reference

12 December 2020

The immunosuppressive peptide of HIV-1 gp41 like human type I interferons up-regulates MHC class I expression on H9 and U937 cells

1 reference

12 December 2020

HIV-1 gp41 by a common immunological epitope induces increased levels of antibodies against human interferon-beta in HIV-1 positive individuals

1 reference

12 December 2020

T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors

1 reference

12 December 2020

HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41

1 reference

12 December 2020

A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-IFN alpha immunization.

1 reference

12 December 2020

A peptide inhibitor of human immunodeficiency virus infection binds to novel human cell surface polypeptides.

1 reference

12 December 2020

One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategy

1 reference

12 December 2020

HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation

1 reference

12 December 2020

Epitope-vaccines: a new strategy to induce high levels of neutralizing antibodies against HIV-1

1 reference

12 December 2020

HIV-2 transmembrane protein gp36 like HIV-1 gp41 binds to human lymphocytes and monocytes

1 reference

12 December 2020

HIV-1 gp41 enhances major histocompatibility complex class I and ICAM-1 expression on H9 and U937 cells

1 reference

12 December 2020

Epitope vaccine: a new strategy against HIV-1

1 reference

12 December 2020

Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences

1 reference

12 December 2020

Antibodies to HIV-1 gp41 recognize synthetic peptides of human IFN-alpha and IFN-beta

1 reference

12 December 2020

HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9.

1 reference

12 December 2020

1 reference

12 December 2020

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

12 December 2020

The role of three domains in the biological activity of human interferon-alpha

1 reference

12 December 2020

T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor.

1 reference

12 December 2020

A common immunological epitope existing between HIV-1 gp41 and human interferon-alpha and -beta.

1 reference

12 December 2020

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

12 December 2020

The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.

1 reference

12 December 2020

Effects of bacteria-produced human alpha, beta, and gamma interferons on in vitro immune functions

1 reference

12 December 2020

IFN alpha kinoid vaccine in conjunction with tritherapy, a weapon to combat immunopathogenesis in AIDS.

1 reference

12 December 2020

A common epitope on gp41, IFN-alpha and IFN-beta induces protective activity

1 reference

12 December 2020

1 reference

12 December 2020

Increased levels of antibodies against interferon-alpha in HIV-1 positive individuals may be explained by a common immunological epitope on the human interferon-alpha and HIV-1 gp41

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:22:1:61

1 reference

Dimensions Publication ID

30 July 2017

1038592748

0 references

1 reference